North Capital, Inc.

Position in ABBV — AbbVie Inc.

CIK 2065938 SALT LAKE CITY, UT

Position in ABBV

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$483,148

+$59,478 QoQ

Shares Held

1,920

-1.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.09%

of 13F equity value

Holder Rank

#3,193

of 4,152 holders

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

North Capital, Inc. holds $1,795,940 across 5 Drug Manufacturers - General names. ABBV ranks #1 (26.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	1,920	$483,148
2	JNJ	Johnson & Johnson	1,554	$394,669
3	MRK	Merck & Co., Inc.	2,957	$379,974
4	LLY	ELI LILLY & Co	230	$275,868
5	GILD	Gilead Sciences, Inc.	2,076	$262,281

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$483,148	1,920	-1.4%	Shares	Sole	2026-07-14
2026-03-31	$423,670	1,948	+5.4%	Shares	Sole	2026-04-30
2025-09-30	$428,117	1,849	+11.3%	Shares	Sole	2025-10-09
2025-06-30	$308,314	1,661	-9.7%	Shares	Sole	2025-08-06
2025-03-31	$385,307	1,839	—	Shares	Sole	2025-04-28
No filing history on record for this holder in this stock.